Chen Xin is an associate professor and master's supervisor in Northwest A&F university in China. He obtained his bachelor's degree in 2010 and his Ph.D. in Medicinal Chemistry in 2015, both from China Pharmaceutical University.
His roles include serving as an expert reviewer for undergraduate thesis evaluations under the Ministry of Education, a leading entrepreneurial talent under Yangzhou's "Lüyang Jinfeng" program, a "Technology Deputy" in Jiangsu Province, and a committee member of the Medicinal Chemistry Professional Committee in Shaanxi Province.
His primary research focuses on the design and synthesis of HDAC and kinase inhibitors, as well as the evaluation of their anti-cancer and anti-Alzheimer's disease activities. He has published over 20 SCI-indexed papers and has led more than 10 national and provincial-level research projects.
Chen Xin is an associate professor and master's supervisor in Northwest A&F university in China. He obtained his bachelor's degree in 2010 and his Ph.D. in Medicinal Chemistry in 2015, both from China Pharmaceutical University.
His roles include serving as an expert reviewer for undergraduate thesis evaluations under the Ministry of Education, a leading entrepreneurial talent under Yangzhou's "Lüyang Jinfeng" program, a "Technology Deputy" in Jiangsu Province, and a committee member of the Medicinal Chemistry Professional Committee in Shaanxi Province.
His primary research focuses on the design and synthesis of HDAC and kinase inhibitors, as well as the evaluation of their anti-cancer and anti-Alzheimer's disease activities. He has published over 20 SCI-indexed papers and has led more than 10 national and provincial-level research projects.